WallStSmart
STXS

Stereotaxis Inc

NYSE MKT: STXS · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$1.87
+2.75% today

Updated 2026-04-30

Market cap
$188.13M
P/E ratio
P/S ratio
5.81x
EPS (TTM)
$-0.25
Dividend yield
52W range
$2 – $4
Volume
0.4M

Stereotaxis Inc (STXS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
+1.6%
Last 4 quarters
Revenue YoY growth
+36.3%
Most recent quarter
EPS YoY growth
+33.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-8.4%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-12.9%
2025-11-11
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-09$-0.06-9.1%$2.05$1.97-3.9%
2025-11-11$-0.07-16.7%$2.79$2.43-12.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.06$-0.06-9.1%$8.64M+36.3%
2025-09-30$-0.06$-0.07-16.7%$7.46M-18.8%
2025-06-30$-0.07$-0.05+28.6%$8.80M+95.4%
2025-03-31$-0.07$-0.07+3.4%$7.47M+8.6%
2024-12-31$-0.07$-0.09-38.5%$6.34M+38.9%
2024-09-30$-0.05$-0.08-60.0%$9.20M+17.9%
2024-06-30$-0.05$-0.07-40.0%$4.50M-42.7%
2024-03-31$-0.06$-0.06+0.0%$6.88M+5.1%
2023-12-31$-0.07$-0.07+0.0%$4.57M
2023-09-30$-0.06$-0.07-16.7%$7.80M
2023-06-30$-0.07$-0.07+0.0%$7.86M
2023-03-31$-0.06$-0.07-16.7%$6.55M

Frequently asked questions

Has Stereotaxis Inc beaten earnings estimates?
Stereotaxis Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of +1.6% over the last 4 quarters.
How does STXS stock react to earnings?
STXS stock has moved an average of -8.4% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Stereotaxis Inc's revenue growth rate?
Stereotaxis Inc reported year-over-year revenue growth of +36.3% in its most recent quarter, with EPS growing +33.3% year-over-year.